News


All series


All News

Neurostimulation could be the “next big thing” in dry eye disease (DED). A new neurostimulation device called TrueTear (Allergan) is a patient-directed, non-pharmacologic option.

Creating a positive first impression is more than a significant factor during our patients’ first contact with our practices, which is almost always via a telephone call. During the initial conversation, our soon-to-be patients are faced with a fundamental decision-are they comfortable with what they perceive as our practices’ personality? Is it a good fit?

grew up in the Triangle area, Raleigh-Durham, NC. I spent time in Orlando, came back to North Carolina for college and for optometry school I went to Pennsylvania School of Optometry in Philadelphia.

Innovation does not cease and nor should our ability to stay abreast of the latest surgical options for our patients. The ever-growing population of presbyopes is endless, and the desire to rid oneself of spectacles is unquenchable.

I've been witness of late to a lot of workplace conflict. It is my nature to avoid conflict. I'm certain it’s because I dealt with a lifetime of workplace conflict when I was a supervisor in the coal mines.

You know the statistics. Nearly 40% of Americans don’t go to the eye doctor because they feel like their eyes are “fine,” and despite efforts by the AOA and outreach campaigns, the average American is also getting bombarded by telemedicine ads painting eyecare as “inconvenient” and “expensive.”

When is the last time that you performed an eye exam for an energetic two-year-old? Does the thought scare you, or do you refer these patients to the nearest pediatric specialist? With just a little patience and a quick response time, you, too, can perform a 2-year-old eye exam as smoothly as an adult eye exam (sometimes even easier).

So much basic science research is presented at this meeting, and most of it will be years before it makes its way to clinical trials. Let’s concentrate on research that might be of use to us in the exam room very soon.

As a lecturer and clinical instructor in vision therapy and pediatrics, it is important to have a literature base for what I am teaching. My top 10 favorite vision therapy books provide that evidence base and offer a varied clinical approach for all optometrists who to offer vision therapy in their practices or simply understand the visual process on a higher level.

As an allergy sufferer myself, I tend to pore over the journals and literature to learn what new exciting technologies may be on the horizon. When I came across epicutaneous immunotherapy (EPIT), my mind went in a multitude of different directions about the endless possibilities for both systemic and ocular allergy management.

Diabetic retinopathy (DR) in patients is a common finding in optometric practices. When we grade the level of retinopathy, we often do so with findings of the Early Treatment Diabetic Retinopathy Study (ETDRS)in mind.